Add BrightSurf on Google Email

Autologous bone marrow-derived mononuclear cell transplants can reduce diabetic amputations

Researchers found that autologous bone marrow-derived mononuclear cell transplants can significantly induce vascular growth, reducing the number of amputations in patients with diabetes suffering from critical limb ischemia. The study showed a significant increase in neovasculogenesis and a decrease in PAD mortality.